NovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products at the 126th Annual American Optometric Association Congress
20 Juin 2023 - 12:50PM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company
developing and commercializing high-quality eyecare, skincare and
wound care products, announces that it will showcase its
Avenova®-branded eyecare products at the 126th Annual American
Optometric Association (AOA) Congress & 55th Annual American
Optometric Student Association (AOSA) Conference:
Optometry's Meeting® being held June 21-24, 2023 at the Walter E.
Washington Convention Center in Washington, D.C. The full line of
Avenova dry eye products will be displayed at booth #821 in
exhibition hall D&E.
“We invite conference attendees to learn about our extensive
line of evidence-led, differentiated and highly effective
Avenova-branded products to manage the multifactorial and complex
issue of chronic dry eye,” said Justin Hall, NovaBay CEO. “Through
our physician-dispensed channel, we make our superior-quality
products available for resale by eyecare professionals to their
patients. Conference attendees can stop by our booth to discover
our new products, sample the full line of Avenova products and take
advantage of exclusive AOA conference specials.”
NovaBay offers best-in-class Avenova-branded products for each
step of the standard dry-eye treatment regimen, including Avenova
spray, the No. 1 doctor-recommended lid and lash cleanser,
lubricating eye drops for instant relief, a warm eye compress to
soothe, an antioxidant-rich dietary supplement with omega-3 oils
and the i-Chek to monitor physical eyelid health. Eyecare
professionals interested in learning more about the Avenova
physician-dispensed program should email sales@novabay.com or call
510-899-8841.
About Optometry’s Meeting
With expert-led continuing education and professional
development (CEE/TQ, AOA CE hours, CPC and COPE credit) available
for doctors, paraoptometrics and students, Optometry’s Meeting
delivers education that supports every member of the care team.
From courses focused on office-based surgical skills and procedures
to practical guidance on everything from building a medical contact
lens practice to financially preparing for every stage of a career,
Optometry’s Meeting is packed with discovery, interdisciplinary
collaboration and experiential opportunities. Like no other
meeting, Optometry’s Meeting gives every industry professional the
unprecedented opportunity to effect lasting change in the
profession and make the AOA a stronger, more effective advocate for
the quality eye health and vision care services for patients.
About NovaBay Pharmaceuticals, Inc.:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically
created and clinically proven eyecare and skincare products.
NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash
Solution, is often prescribed by eyecare professionals for
blepharitis and dry-eye disease and is also available directly to
eyecare consumers through online distribution channels such as
Amazon. DERMAdoctor® offers more than 30 dermatologist-developed
skincare products through the DERMAdoctor website, well-known
traditional and digital beauty retailers, and international
distributors. NovaBay also manufactures and sells effective, yet
gentle and non-irritating wound care products. The PhaseOne® brand
is distributed through commercial partners in the U.S. for
professional use only, and the NeutroPhase® brand is distributed in
China by Pioneer Pharma (Hong Kong) Company Ltd.
NovaBay Pharmaceuticals Forward-Looking Statements
Except for historical information herein, matters set forth in
this press release may be forward looking within the meaning of the
“safe harbor” provisions of the Private Securities Litigation
Reform Act of 1995, including statements about the commercial
progress and future financial performance of NovaBay
Pharmaceuticals, Inc. This release contains forward-looking
statements that are based upon management’s current expectations,
assumptions, estimates, projections and beliefs. These statements
include, but are not limited to, statements regarding our business
strategies, current partnerships, marketing efforts, and any future
revenue that may result from such partnerships and related
marketing initiatives, as well as generally the Company’s expected
future financial results. These statements involve known and
unknown risks, uncertainties and other factors that may cause
actual results or achievements to be materially different and
adverse from those expressed in or implied by the forward-looking
statements. Factors that might cause or contribute to such
differences include, but are not limited to, risks and
uncertainties relating to the size of the potential market for our
products, the possibility that the available market for the
Company’s products will not be as large as expected, the Company’s
products will not be able to penetrate one or more targeted
markets, and revenues will not be sufficient to meet the Company’s
cash needs. Other risks relating to NovaBay’s business, including
risks that could cause results to differ materially from those
projected in the forward-looking statements in this press release,
are detailed in NovaBay’s latest Form 10-Q/K filings and
Registration Statement on Form S-1 filing with the Securities and
Exchange Commission, especially under the heading “Risk Factors.”
The forward-looking statements in this release speak only as of
this date, and NovaBay disclaims any intent or obligation to revise
or update publicly any forward-looking statement except as required
by law.
Socialize and Stay Informed on
NovaBay’s Progress
Like us on Facebook Follow us on Twitter Connect with NovaBay on
LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information
For NovaBay Avenova purchasing information: Please call
800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information
For DERMAdoctor purchasing information: Please call 877-337-6237
or email service@dermadoctor.com DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230620521505/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024